GW&K Investment Management LLC Sells 26,266 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

GW&K Investment Management LLC lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 7.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 345,715 shares of the company's stock after selling 26,266 shares during the quarter. GW&K Investment Management LLC owned about 2.31% of U.S. Physical Therapy worth $32,200,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of USPH. Vanguard Group Inc. raised its position in U.S. Physical Therapy by 1.7% during the 3rd quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company's stock valued at $95,051,000 after purchasing an additional 17,156 shares during the last quarter. Semanteon Capital Management LP bought a new stake in shares of U.S. Physical Therapy during the 4th quarter valued at $767,000. Schroder Investment Management Group increased its position in U.S. Physical Therapy by 12.1% in the third quarter. Schroder Investment Management Group now owns 384,936 shares of the company's stock worth $35,310,000 after buying an additional 41,414 shares in the last quarter. First Dallas Securities Inc. bought a new stake in U.S. Physical Therapy during the 3rd quarter worth approximately $1,073,000. Finally, Louisiana State Employees Retirement System purchased a new position in U.S. Physical Therapy during the fourth quarter valued at $699,000.

U.S. Physical Therapy Trading Up 0.3 %

USPH traded up $0.34 on Tuesday, hitting $105.74. The company had a trading volume of 39,467 shares, compared to its average volume of 68,133. The company's fifty day moving average price is $105.48 and its 200 day moving average price is $97.65. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 1 year low of $78.08 and a 1 year high of $124.11. The firm has a market cap of $1.59 billion, a P/E ratio of 86.18, a PEG ratio of 4.07 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing analysts' consensus estimates of $0.58 by ($0.07). The company had revenue of $155.70 million for the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. The business's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.59 earnings per share. As a group, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.9 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Thursday, May 23rd will be given a $0.44 dividend. The ex-dividend date is Wednesday, May 22nd. This represents a $1.76 dividend on an annualized basis and a yield of 1.66%. U.S. Physical Therapy's dividend payout ratio (DPR) is 143.09%.

Insider Activity

In related news, COO Graham D. Reeve sold 2,629 shares of the firm's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now owns 6,902 shares in the company, valued at $720,499.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 2,629 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.39, for a total value of $274,441.31. Following the completion of the sale, the chief operating officer now directly owns 6,902 shares of the company's stock, valued at approximately $720,499.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Clayton Trier sold 400 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $107.00, for a total transaction of $42,800.00. Following the transaction, the director now owns 7,000 shares in the company, valued at $749,000. The disclosure for this sale can be found here. Insiders have sold a total of 17,553 shares of company stock valued at $1,852,823 over the last quarter. Corporate insiders own 1.70% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on USPH shares. Barrington Research reaffirmed an "outperform" rating and issued a $122.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the company an "overweight" rating in a report on Wednesday, March 13th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Monday, March 18th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.